News – Page 354 – Endpoints News

Serum Institute subsidiary invests another $150M into Biocon

3 years ago

J&J's consumer health spinout Kenvue lines up a $3B+ IPO, biggest health offering since 2018

3 years ago

Enanta sells off over 50% of royalty payments from Mavyret in exchange for $200M

3 years ago

Florida sues FDA again over Canadian drug import plan

3 years ago

Sun Pharma temporarily halts shipments from manufacturing plant after FDA letter

3 years ago

FDA approves Biogen’s ALS drug tofersen, paving new road for accelerated pathway in neuro diseases

3 years ago

Aurinia extends ‘uncomfortable’ kidney campaign with spokesperson Toni Braxton

3 years ago

How clinical trial advertising went from old-school tactics to splashy strategies to compete in a fierce market

3 years ago

MarketingRx roundup: HHS' Covid campaign continues as health emergency end nears; Pharmas celebrate Earth Day

3 years ago

Ideaya goes forward with $150M offering after touting PhII cancer data

3 years ago

Bipartisan Senate legislation to reform PBMs, improve FDA processes kicks off with a markup next week

3 years ago

FDA hands Arbutus clinical hold on IND for hepatitis PD-L1

3 years ago

‘Dawn of oral therapy’: Morphic touts UC data in march toward Takeda’s Entyvio

3 years ago

Novartis pays German biotech $40M for radioligand therapy, diagnostic hitting 'first-in-class' target

3 years ago

Updated: Novartis trims pipeline by 10% as Vas Narasimhan places premium on 'high-value medicines'

3 years ago

Updated: Biogen chops certain stroke and RNA therapy programs as it continues R&D revamp

3 years ago

Florida-based biotech with approved cardiovascular therapy moves to go public via SPAC

3 years ago

$200M SPAC funded by billionaire Michael Dell will unwind after failing to find a partner

3 years ago

From CRL to buyout in five months: Assertio to acquire Spectrum in $248M stock deal

3 years ago

Vertex buys in on Stablix's protein stabilization approach in research and licensing deal

3 years ago

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

3 years ago

Ferring builds out partnerships, taps social media to amplify fertility conversations

3 years ago

Samsung Biologics to expand manufacturing in South Korea; WuXi AppTec expects up to 7% revenue growth this year

3 years ago

Genmab to appeal Darzalex arbitration against J&J

3 years ago

First page Previous page 351 352 353354355 356 357 Next page Last page